China Universal Asset Management Co., Ltd. Day One Biopharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 19,203 shares of DAWN stock, worth $226,595. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,203
Previous 10,268
87.02%
Holding current value
$226,595
Previous $141,000
89.36%
% of portfolio
0.03%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
84MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$92.9 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$75.9 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$69.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$57.5 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$53.5 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $867M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...